Skip to main content
. 2015 Jan 19;50(1):59–71. doi: 10.1310/hjp5001-059

Table 1. US Food and Drug Administration–approved indications for nonbenzodiazepine hypnotics 17.

Agent Class Indications
Treatment of insomnia characterized by difficulty with sleep onset Treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance Treatment of insomnia characterized by difficulties with sleep maintenance

Suvorexant Orexin receptor antagonist X

Doxepin Tricyclic antidepressant X

Eszopiclone Benzodiazepine receptor agonist X

Ramelteon Melatonin receptor agonist X

Zaleplon Benzodiazepine receptor agonist X

Zolpidem extended release Benzodiazepine receptor agonist X

Zolpidem immediate release Benzodiazepine receptor agonist X